Statins and GLP 1 What You Haven’t Been Told

In this solo commentary, Nick Norwitz outlines his recent viral social‑media campaign that drew millions of views and media attention by spotlighting a human‑controlled trial showing that statins induce insulin resistance and markedly lower GLP‑1 levels in humans. He emphasizes that his intent is not to advise patients to stop or start statins, but to ensure doctors and patients are aware of these findings so they can make informed decisions and obtain proper consent. Norwitz criticizes the pushback from detractors, accusing them of ignoring the data, and argues that the lack of awareness among clinicians stems from financial incentive structures that obscure the true purpose of medicine—personalized patient care. He frames the issue as a systemic problem rather than individual malfeasance.










